Livzon Pharmaceutical Group Inc. (SHE: 000513)

Livzon Pharmaceutical Group Statistics

Total Valuation

Livzon Pharmaceutical Group has a market cap or net worth of CNY 31.79 billion. The enterprise value is 24.95 billion.

Market Cap	31.79B
Enterprise Value	24.95B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jul 8, 2024

Share Statistics

Livzon Pharmaceutical Group has 916.77 million shares outstanding. The number of shares has decreased by -0.98% in one year.

Shares Outstanding	916.77M
Shares Change (YoY)	-0.98%
Shares Change (QoQ)	-2.40%
Owned by Insiders (%)	0.39%
Owned by Institutions (%)	15.02%
Float	484.63M

Valuation Ratios

The trailing PE ratio is 18.15 and the forward PE ratio is 16.46.

PE Ratio	18.15
Forward PE	16.46
PS Ratio	3.00
PB Ratio	2.59
P/FCF Ratio	12.50
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.99, with an EV/FCF ratio of 8.72.

EV / Earnings	12.54
EV / Sales	2.08
EV / EBITDA	8.99
EV / EBIT	11.62
EV / FCF	8.72

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.28.

Current Ratio	1.81
Quick Ratio	1.58
Debt / Equity	0.28
Debt / EBITDA	1.46
Debt / FCF	1.41
Interest Coverage	21.55

Financial Efficiency

Return on equity (ROE) is 14.40% and return on invested capital (ROIC) is 7.23%.

Return on Equity (ROE)	14.40%
Return on Assets (ROA)	5.23%
Return on Capital (ROIC)	7.23%
Revenue Per Employee	1.35M
Profits Per Employee	223,100
Employee Count	8,933
Asset Turnover	0.47
Inventory Turnover	2.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.44% in the last 52 weeks. The beta is 0.27, so Livzon Pharmaceutical Group's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	+7.44%
50-Day Moving Average	36.67
200-Day Moving Average	37.14
Relative Strength Index (RSI)	59.54
Average Volume (20 Days)	6,920,321

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Livzon Pharmaceutical Group had revenue of CNY 12.02 billion and earned 1.99 billion in profits. Earnings per share was 2.15.

Revenue	12.02B
Gross Profit	7.51B
Operating Income	2.15B
Pretax Income	2.57B
Net Income	1.99B
EBITDA	2.75B
EBIT	2.15B
Earnings Per Share (EPS)	2.15

Balance Sheet

The company has 11.57 billion in cash and 4.04 billion in debt, giving a net cash position of 7.53 billion or 8.21 per share.

Cash & Cash Equivalents	11.57B
Total Debt	4.04B
Net Cash	7.53B
Net Cash Per Share	8.21
Equity (Book Value)	14.61B
Book Value Per Share	15.06
Working Capital	7.81B

Cash Flow

In the last 12 months, operating cash flow was 3.55 billion and capital expenditures -691.57 million, giving a free cash flow of 2.86 billion.

Operating Cash Flow	3.55B
Capital Expenditures	-691.57M
Free Cash Flow	2.86B
FCF Per Share	3.12

Margins

Gross margin is 62.51%, with operating and profit margins of 17.86% and 16.55%.

Gross Margin	62.51%
Operating Margin	17.86%
Pretax Margin	21.36%
Profit Margin	16.55%
EBITDA Margin	22.91%
EBIT Margin	17.86%
FCF Margin	23.79%

Dividends & Yields

This stock pays an annual dividend of 1.35, which amounts to a dividend yield of 3.40%.

Dividend Per Share	1.35
Dividend Yield	3.40%
Dividend Growth (YoY)	-15.63%
Years of Dividend Growth	3
Payout Ratio	68.52%
Buyback Yield	0.98%
Shareholder Yield	4.38%
Earnings Yield	5.51%
FCF Yield	8.00%

Stock Splits

The last stock split was on July 3, 2019. It was a forward split with a ratio of 1.3.

Last Split Date	Jul 3, 2019
Split Type	Forward
Split Ratio	1.3

Scores

Livzon Pharmaceutical Group has an Altman Z-Score of 3.37.

Altman Z-Score	3.37
Piotroski F-Score	n/a